Simplifying manufacturing of saRNA replicons

Making the transition to a more efficient RNA capping process can be challenging. TriLink BioTechnologies has a solution. This technical note explores how CleanCap® AU technology simplifies the production process of saRNAs, delivering higher yields and greater efficiency compared to traditional methods. With clear benefits for the development of novel RNA-based treatments, including cancer vaccines, this resource is essential for those aiming to optimise their processes. Fill in your details to find out more.